SentiSense Logo

SentiSense

Ctrl+K

55% OFF

Quick tip: Press

K

to search stocks

B

BSX

Boston Scientific Corporation

$71.35

-1.64 (-2.25%)

Summary

Stories

News

Metrics

Fundamentals

Current Market Valuation

Current Price

$71.35

Live market price

P/E (TTM)

36.78

EPS: $1.94

P/S (TTM)

5.27

Price to Sales

TTM Quarters

4

Quarters included in TTM

Updated: 3/8/2026, 5:55:53 AM

Historical Trends

Range:

Revenue Over Time

Q1 2021Q2 2022Q3 2023Q4 2025$0B$2B$4B$6B$8B

Net Income Over Time

Q1 2021Q2 2022Q3 2023Q4 2025$0B$0B$0B$1B$1B

Short Interest (% of Float) Over Time

02/2805/3008/2902/130.0%5.0%10.0%15.0%20.0%High SI

Short Interest

26.6M

% of Float

1.8%

Days to Cover

1.0

Avg Daily Vol

28.0M

Historical income statement data up to 5 years


Historical SEC Filings

Report Period

Debt/Equity

0.56

Leverage ratio

ROE (TTM)

11.82%

Return on equity

Income Statement

Revenue

$20.07B


Cost of Revenue

$6.22B


Gross Profit

$13.85B


Operating Income

$3.61B


Net Income

$2.89B


EPS (Quarter)

$1.94


EPS (TTM)

--

Balance Sheet

Total Assets

$43.67B


Total Liabilities

$19.20B


Shareholders' Equity

$24.47B


Current Assets

$8.79B


Current Liabilities

$5.44B


Cash & Equivalents

--


Long-Term Debt

--

Cash Flow

Operating Cash Flow

$4.53B


Investing Cash Flow

$-2.64B


Financing Cash Flow

$-395.00M


Free Cash Flow

$1.89B

Profitability Margins

Gross Margin

69.01%

Operating Margin

18.00%

Net Profit Margin

14.41%


ROA (TTM)

6.62%


ROE (TTM)

11.82%

Data source: Polygon.io

Last updated: 3/8/2026, 5:55:52 AM

Company Profile

Symbol

BSX


Market Cap

$105.88B


IPO Date

May 18, 1992


CEO

--


Employees

59,000


Sector

--


Industry

SURGICAL & MEDICAL INSTRUMENTS & APPARATUS


Country

United States


Exchange

--

Boston Scientific produces less invasive medical devices that are inserted into the human body through small openings or cuts. It manufactures products for use in angioplasty, blood clot filtration, kidney stone management, cardiac rhythm management, catheter-directed ultrasound imaging, upper gastrointestinal tract diagnostics, interventional oncology, neuromodulation for chronic pain, and treatment of incontinence. The firm markets its devices to healthcare professionals and institutions globally. Foreign sales account for roughly 36% of the firm's total sales.

Read More

Similar Stocks

MDT

Medtronic plc

$90.90

-2.27%

ABT

Abbott Laboratories

$109.56

-1.33%

MDT

Medtronic plc

$90.90

-2.27%

ISRG

Intuitive Surgical, Inc.

$490.16

-1.32%

SentiSense Logo

SentiSense

Sense what the market is doing.

© 2026 Compass AI Data Services, LLC. All rights reserved.


Important Disclaimer: Compass AI Data Services, LLC provides market information, sentiment analysis, and data intelligence. We do not provide investment advice, recommendations, or financial guidance. All information is for informational purposes only. Users are solely responsible for their own investment decisions. Always consult a licensed financial advisor before making investment decisions.

Cookie Preferences

We use cookies to enhance your experience and analyze site traffic. Privacy Policy